术前复发评分:预测肝周胆管癌的早期复发。

IF 3.5 2区 医学 Q2 ONCOLOGY
Ejso Pub Date : 2024-10-05 DOI:10.1016/j.ejso.2024.108745
Simone Conci , Giovanni Catalano , Wojciech Polak , Francesco Ardito , Mario De Bellis , Edoardo Poletto , Caterina Mele , Laura Alaimo , Felice Giuliante , Bas Groot Koerkamp , Andrea Ruzzenente
{"title":"术前复发评分:预测肝周胆管癌的早期复发。","authors":"Simone Conci ,&nbsp;Giovanni Catalano ,&nbsp;Wojciech Polak ,&nbsp;Francesco Ardito ,&nbsp;Mario De Bellis ,&nbsp;Edoardo Poletto ,&nbsp;Caterina Mele ,&nbsp;Laura Alaimo ,&nbsp;Felice Giuliante ,&nbsp;Bas Groot Koerkamp ,&nbsp;Andrea Ruzzenente","doi":"10.1016/j.ejso.2024.108745","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Despite advances in surgical techniques, the rate of early recurrence in perihilar cholangiocarcinoma (PCC) remains high. We sought to develop the Preoperative Recurrence Score (PRS), a model to estimate the risk of early recurrence after resection based on preoperative radiological characteristics.</div></div><div><h3>Materials and methods</h3><div>Data of patients who underwent surgery for PCC were retrospectively collected, and preoperative imaging was reviewed to assess tumor characteristics. A model to assess the risk of early recurrence based on preoperative radiologic characteristics was internally developed and externally validated on two cohorts of patients from two European major hepatobiliary surgery referral centers.</div></div><div><h3>Results</h3><div>A total of 215 patients among three different patient cohorts were included in the study. Tumor size ≥18 mm (HR 2.70, 95 % CI 1.48–4.92, p = 0.001), macroscopic portal vein involvement (HR 2.28, 95%CI 1.19–4.34, p = 0.013), hepatic arteries involvement (HR 2.44, 95%CI 1.26–4.71, p = 0.008), and presence of suspicious lymph nodes (HR 1.98, 95%CI 1.02–3.83, p = 0.043) were significantly associated with recurrence-free survival (RFS). The model showed excellent discrimination both on the internal (AUC 0.83) and external validation cohorts (external 1: AUC 0.84; external 2: AUC 0.70). High PRS was associated with worse RFS among all three cohorts, with a 1-year recurrence probability of 80.1 %, 100.0 %, and 54.2 % in the internal and external validation cohorts 1 and 2, respectively.</div></div><div><h3>Conclusions</h3><div>The PRS is a simple tool that can accurately assess the risk of early recurrence in patients with PCC. Up-front surgery should be carefully evaluated in patients with high PRS, as it could result in a futile resection.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"50 12","pages":"Article 108745"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The preoperative recurrence score: Predicting early recurrence in peri-hilar cholangiocarcinoma\",\"authors\":\"Simone Conci ,&nbsp;Giovanni Catalano ,&nbsp;Wojciech Polak ,&nbsp;Francesco Ardito ,&nbsp;Mario De Bellis ,&nbsp;Edoardo Poletto ,&nbsp;Caterina Mele ,&nbsp;Laura Alaimo ,&nbsp;Felice Giuliante ,&nbsp;Bas Groot Koerkamp ,&nbsp;Andrea Ruzzenente\",\"doi\":\"10.1016/j.ejso.2024.108745\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Despite advances in surgical techniques, the rate of early recurrence in perihilar cholangiocarcinoma (PCC) remains high. We sought to develop the Preoperative Recurrence Score (PRS), a model to estimate the risk of early recurrence after resection based on preoperative radiological characteristics.</div></div><div><h3>Materials and methods</h3><div>Data of patients who underwent surgery for PCC were retrospectively collected, and preoperative imaging was reviewed to assess tumor characteristics. A model to assess the risk of early recurrence based on preoperative radiologic characteristics was internally developed and externally validated on two cohorts of patients from two European major hepatobiliary surgery referral centers.</div></div><div><h3>Results</h3><div>A total of 215 patients among three different patient cohorts were included in the study. Tumor size ≥18 mm (HR 2.70, 95 % CI 1.48–4.92, p = 0.001), macroscopic portal vein involvement (HR 2.28, 95%CI 1.19–4.34, p = 0.013), hepatic arteries involvement (HR 2.44, 95%CI 1.26–4.71, p = 0.008), and presence of suspicious lymph nodes (HR 1.98, 95%CI 1.02–3.83, p = 0.043) were significantly associated with recurrence-free survival (RFS). The model showed excellent discrimination both on the internal (AUC 0.83) and external validation cohorts (external 1: AUC 0.84; external 2: AUC 0.70). High PRS was associated with worse RFS among all three cohorts, with a 1-year recurrence probability of 80.1 %, 100.0 %, and 54.2 % in the internal and external validation cohorts 1 and 2, respectively.</div></div><div><h3>Conclusions</h3><div>The PRS is a simple tool that can accurately assess the risk of early recurrence in patients with PCC. Up-front surgery should be carefully evaluated in patients with high PRS, as it could result in a futile resection.</div></div>\",\"PeriodicalId\":11522,\"journal\":{\"name\":\"Ejso\",\"volume\":\"50 12\",\"pages\":\"Article 108745\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-10-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ejso\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0748798324008023\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798324008023","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言:尽管手术技术不断进步,但肝周胆管癌(PCC)的早期复发率仍然很高。我们试图开发术前复发评分(PRS),这是一种根据术前放射学特征估算切除术后早期复发风险的模型:回顾性收集了接受PCC手术的患者数据,并回顾了术前影像学检查以评估肿瘤特征。根据术前影像学特征评估早期复发风险的模型由内部开发,并在欧洲两大肝胆外科转诊中心的两组患者中进行了外部验证:研究共纳入了三个不同患者队列中的 215 名患者。肿瘤大小≥18 mm (HR 2.70, 95 % CI 1.48-4.92, p = 0.001)、门静脉大面积受累 (HR 2.28, 95 %CI 1.19-4.34, p = 0.013)、肝动脉受累 (HR 2.44,95%CI 1.26-4.71,p = 0.008)和可疑淋巴结(HR 1.98,95%CI 1.02-3.83,p = 0.043)与无复发生存期(RFS)显著相关。该模型在内部队列(AUC 0.83)和外部验证队列(外部 1:AUC 0.84;外部 2:AUC 0.70)中均显示出极佳的区分度。在所有三个队列中,高PRS与较差的RFS相关,在内部和外部验证队列1和2中,1年复发概率分别为80.1%、100.0%和54.2%:PRS是一种能准确评估PCC患者早期复发风险的简单工具。对于PRS较高的患者,应谨慎评估前期手术,因为这可能会导致徒劳的切除。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The preoperative recurrence score: Predicting early recurrence in peri-hilar cholangiocarcinoma

Introduction

Despite advances in surgical techniques, the rate of early recurrence in perihilar cholangiocarcinoma (PCC) remains high. We sought to develop the Preoperative Recurrence Score (PRS), a model to estimate the risk of early recurrence after resection based on preoperative radiological characteristics.

Materials and methods

Data of patients who underwent surgery for PCC were retrospectively collected, and preoperative imaging was reviewed to assess tumor characteristics. A model to assess the risk of early recurrence based on preoperative radiologic characteristics was internally developed and externally validated on two cohorts of patients from two European major hepatobiliary surgery referral centers.

Results

A total of 215 patients among three different patient cohorts were included in the study. Tumor size ≥18 mm (HR 2.70, 95 % CI 1.48–4.92, p = 0.001), macroscopic portal vein involvement (HR 2.28, 95%CI 1.19–4.34, p = 0.013), hepatic arteries involvement (HR 2.44, 95%CI 1.26–4.71, p = 0.008), and presence of suspicious lymph nodes (HR 1.98, 95%CI 1.02–3.83, p = 0.043) were significantly associated with recurrence-free survival (RFS). The model showed excellent discrimination both on the internal (AUC 0.83) and external validation cohorts (external 1: AUC 0.84; external 2: AUC 0.70). High PRS was associated with worse RFS among all three cohorts, with a 1-year recurrence probability of 80.1 %, 100.0 %, and 54.2 % in the internal and external validation cohorts 1 and 2, respectively.

Conclusions

The PRS is a simple tool that can accurately assess the risk of early recurrence in patients with PCC. Up-front surgery should be carefully evaluated in patients with high PRS, as it could result in a futile resection.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ejso
Ejso 医学-外科
CiteScore
6.40
自引率
2.60%
发文量
1148
审稿时长
41 days
期刊介绍: JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信